• Home
  • Join the Alliance
    • About Us
    • Our Members
    • Become a Member
    • Join the PA Team
  • Join A Project
    • All Projects
    • Chemical Safety Library Project
    • DataFAIRy Bioassay Annotation Project
    • Diversity & Inclusion in STEM Leadership Program
    • FAIR Implementation Project
    • IDMP Ontology Project
    • Microbiome Project
    • Natural Language Processing Use Case Database Project
    • Semantic Enrichment of ELN Data Project
  • Join a Community
    • All Communities
    • Artificial Intelligence & Machine Learning
    • Clinical Trial Environmental Impact
    • Controlled Substance Compliance
    • Lab of the Future
    • Pistoia Alliance/FDA In Vitro Pharmacology
    • Quantum Computing
    • Social Media & Real-World Evidence
    • User Experience for Life Sciences
  • Submit an Idea
  • Events
    • All events
    • Submit an Event
    • Sponsor a Webinar
    • Global Knowledge-Sharing Events
    • Past Webinars
  • News

  • Home
  • Join the Alliance
    • About Us
    • Our Members
    • Become a Member
    • Join the PA Team
  • Join A Project
    • All Projects
    • Chemical Safety Library Project
    • DataFAIRy Bioassay Annotation Project
    • Diversity & Inclusion in STEM Leadership Program
    • FAIR Implementation Project
    • IDMP Ontology Project
    • Microbiome Project
    • Natural Language Processing Use Case Database Project
    • Semantic Enrichment of ELN Data Project
  • Join a Community
    • All Communities
    • Artificial Intelligence & Machine Learning
    • Clinical Trial Environmental Impact
    • Controlled Substance Compliance
    • Lab of the Future
    • Pistoia Alliance/FDA In Vitro Pharmacology
    • Quantum Computing
    • Social Media & Real-World Evidence
    • User Experience for Life Sciences
  • Submit an Idea
  • Events
    • All events
    • Submit an Event
    • Sponsor a Webinar
    • Global Knowledge-Sharing Events
    • Past Webinars
  • News
Become a Member
Search

Search...

  • Menu

MEDIA ALERT

Pistoia Alliance President Warns Pharmaceutical Industry Not to Undo the Advances it has Made During the Pandemic

Tackling global public health crises will require industry to continue overcoming trust issues and accelerate the safe sharing of anonymized patient data

Boston, October 6, 2021: Dr. Steve Arlington, President of the Pistoia Alliance, a global not-for-profit advocating for greater collaboration in biopharma, is calling on the pharmaceutical industry to continue building on the advances in collaboration it has built over the past two years. Digital transformation has accelerated rapidly during the pandemic, which in turn has greatly improved remote patient monitoring, rapid online triage of patients, and the sharing of data. Dr. Arlington is now urging organizations not to let old behaviors return to slow down progress.

 

“While we have made incredible scientific gains to address COVID-19, there are still many disease areas where very little has progressed in the last four decades, in terms of both treatments and outcomes for patients. Organizations must continue to work together to develop new therapies in areas such as dementia, for instance, one of the biggest challenges facing humans today. Society is now considering how we care for an aging population and research must be focused on improving outcomes for all types of dementia,” commented Dr. Arlington. “Another devasting disease we need to urgently address is pancreatic cancer. Currently, the combined five-year survival rate of pancreatic cancer is just 5-10%. Research is the key to improving this outlook and critically, improving early diagnosis. Collaboration will be critical to solving such issues.”

 

To address the numerous public health issues facing society today, global solutions developed through collaboration are required. Stakeholders in governments, regulatory authorities and the biopharmaceutical sector must look for further opportunities to develop a cross-disciplinary approach. Addressing pre-existing hurdles to cooperative working that hinder progress will enable progress in the life sciences at the same pace as has been achieved in developing COVID-19 vaccines. The industry also needs to improve access to real world patient data for use in R&D and put in place infrastructure that will enable safe data sharing.

 

“The biopharmaceutical sector has done a lot during the pandemic to rebuild trust in the industry. It now needs to take that even further to educate the public on the importance of data sharing, including the benefits of sharing their anonymized patient data. Many people have been understandably concerned about sharing personal information, but to enable big breakthroughs in areas like cancer and precision medicine, we all need to altruistically share our data for the greater good of research,” continued Dr. Arlington.

 

The Pistoia Alliance has over 150 members ranging from global research-led organizations and medium enterprises to start-ups and individuals. Members collaborate as equals on projects that generate concrete value for the worldwide life sciences and healthcare community. The Alliance provides members with a legal framework to enable straightforward and secure pre-competitive collaboration. Its full portfolio of projects is accessible here.

 

—ENDS—

 

About the Pistoia Alliance
The Pistoia Alliance is a global, not-for-profit members’ organization made up of life science companies, technology, and service providers, publishers, and academic groups working to lower barriers to innovation in life science and healthcare R&D. It was conceived in 2007 and incorporated in 2009 by representatives of AstraZeneca, GSK, Novartis and Pfizer who met at a conference in Pistoia, Italy. Its projects transform R&D through pre-competitive collaboration. It overcomes common R&D obstacles by identifying the root causes, developing standards and best practices, sharing pre-competitive data and knowledge, and implementing technology pilots. There are currently over 150 member companies; members collaborate on projects that generate significant value for the worldwide life sciences R&D community, using The Pistoia Alliance’s proven framework for open innovation.

 

Media Contact:
Spark Communications
+44 207 436 0420
pistoiaalliance@sparkcomms.co.uk

 

Tanya Randall
The Pistoia Alliance
+44 7887 811332
tanya.randall@pistoiaalliance.org

Join the Mailing List

Posted on October 6, 2021 by Yasheaka Oakley
Categories: Pistoia Alliance News

Tags: collaboration, pistoia alliance


Events

15 Feb 2023

Get to Know the Pistoia Alliance and our Projects

Book this event >
22 Feb 2023 - 23 Feb 2023

SmartLab Exchange

Book this event >
09 Mar 2023 - 10 Mar 2023

Lab of the Future USA Congress

Boston United States
Book this event >
15 Mar 2023

Collaborate to Innovate: Pistoia Alliance Japan Conference

Book this event >
Follow Us
Active Projects
Natural Language Processing (NLP) Use Case Database Project
IDMP Ontology Project
Diversity & Inclusion in STEM Leadership Program
Unified Integrated Knowledge Base
Microbiome Project
Data Visualization Project
Methods Hub Project
Informed Consent Blockchain Project
Quality Generation and Ethical Use of Digital Health Data in Clinical Studies
Semantic Enrichment of ELN Data Project (SEED)
Sign up for Pistoia Alliance Communications

© Copyright Pistoia Alliance, Inc., 2020 | Contact us at info@pistoiaalliance.org | Terms of use | Privacy Statement

By clicking "Agree" you are agreeing to the following terms and conditions for the use of the UDM XML Schema definition.

This website intends to use cookies to improve the site and provide you with a better browsing experience. If you select "Continue" or continue to browse the site without customizing your choices, you agree to our use of cookies. Find out more in our Online Privacy Statement.

Continue More Info